Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

ClinicalTrials.gov ID: NCT01227564

Public ClinicalTrials.gov record NCT01227564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, 24-month, Randomized, Third-party Unblinded, Placebo-controlled, Parallel-group Amyloid Imaging Positron Emission Tomography (Pet) And Safety Trial Of Acc-001 And Qs-21 Adjuvant In Subjects With Early Alzheimer's Disease.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study in individuals with early Alzheimer's disease is designed to assess:(1) safety and tolerability (2) the capacity of ACC-001 and QS-21 adjuvant to reduce brain amyloid load as measured by positron emission tomography (PET) scans.

Study identification

NCT ID
NCT01227564
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
63 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Feb 2014 (Actual)
Completion
Feb 2014 (Actual)
Last update posted
Feb 25, 2016

2011 – 2014

United States locations

U.S. sites
40
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona 85006 —
Banner Good Samaritan Medical Center Phoenix Arizona 85006 —
Banner Boswell Medical Center Sun City Arizona 85351 —
Banner Lakes Imaging Center Sun City Arizona 85351 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
Southwest PET Institute Tucson Arizona 85719 —
University of Arizona, Health Sciences Center - Department of Neurology Tucson Arizona 85724-5023 —
Universal Medical Center Tucson Arizona 85724 —
Northwest NeuroSpecialists, LLC Tucson Arizona 85741 —
Radiology Limited Tucson Arizona 85741 —
Pacific Neuroscience Medical Group Oxnard California 93030 —
GCRC (Drug administered) New Haven Connecticut 06510 —
Yale University School of Medicine, Alzheimer's Disease Research Unit New Haven Connecticut 06510 —
Investigational Drug Service New Haven Connecticut 06511 —
Norman S. Werdiger, MD New Haven Connecticut 06519 —
Clinical Research Unit Washington D.C. District of Columbia 20007 —
Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Georgetown University Medical Center Department of Neurology Washington D.C. District of Columbia 20057 —
Meridien Research Brooksville Florida 34601 —
Florida Neurology Group PL Fort Myers Florida 33907 —
Internal Medicine Associates of Lee County, MD, PA Fort Myers Florida 33912 —
Neuropsychiatric Research Center of Southwest Florida Fort Myers Florida 33912 —
Florida Radiology Leasing, Limited Liability Corporation Fort Myers Florida 33919 —
Radiology Regional Center Fort Myers Florida 33919 —
Miami Jewish Health Systems Miami Florida 33137 —
Mount Sinai Medical Center Miami Beach Florida 33140 —
Premiere Research Institute (Palm Beach Neurology) West Palm Beach Florida 33407 —
Massachusetts General Hospital (For PET only) Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Nebraska Medical Center Omaha Nebraska 68105 —
Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada 89106 —
Steinberg Diagnostic Imaging Las Vegas Nevada 89128 —
Nevada Cancer Institute Las Vegas Nevada 89135 —
Memory Enhancement Center of America, Incorporated Eatontown New Jersey 07724 —
Satatoga PET Associates Clifton Park New York 12065 —
Rhode Island Mood and Memory Research Institute East Providence Rhode Island 02914 —
Butler Hospital Providence Rhode Island 02906 —
Baylor College of Medicine, Department of Neurology Houston Texas 77030 —
The Memory Clinic Bennington Vermont 05201 —
The Pharmacy Inc. Bennington Vermont 05201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01227564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2016 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01227564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →